89 related articles for article (PubMed ID: 22516246)
21. Effect of antipsychotic medication alone vs combined with psychosocial intervention on outcomes of early-stage schizophrenia: A randomized, 1-year study.
Guo X; Zhai J; Liu Z; Fang M; Wang B; Wang C; Hu B; Sun X; Lv L; Lu Z; Ma C; He X; Guo T; Xie S; Wu R; Xue Z; Chen J; Twamley EW; Jin H; Zhao J
Arch Gen Psychiatry; 2010 Sep; 67(9):895-904. PubMed ID: 20819983
[TBL] [Abstract][Full Text] [Related]
22. Quality of life in schizophrenic patients.
Bobes J; Garcia-Portilla MP; Bascaran MT; Saiz PA; Bousoño M
Dialogues Clin Neurosci; 2007; 9(2):215-26. PubMed ID: 17726919
[TBL] [Abstract][Full Text] [Related]
23. The effects of atypical antipsychotic medications on psychosocial outcomes.
Corrigan PW; Reinke RR; Landsberger SA; Charate A; Toombs GA
Schizophr Res; 2003 Sep; 63(1-2):97-101. PubMed ID: 12892863
[TBL] [Abstract][Full Text] [Related]
24. Insight and recovery in schizophrenic patients.
Cannavò D; Minutolo G; Battaglia E; Aguglia E
Int J Psychiatry Clin Pract; 2016; 20(2):83-90. PubMed ID: 26902557
[TBL] [Abstract][Full Text] [Related]
25. The effects of antipsychotic treatment on quality of life of schizophrenic patients under naturalistic treatment conditions: an application of random effect regression models and propensity scores in an observational prospective trial.
Kilian R; Angermeyer MC
Qual Life Res; 2005 Jun; 14(5):1275-89. PubMed ID: 16047503
[TBL] [Abstract][Full Text] [Related]
26. Self-perception of quality of life in patients treated with antipsychotics.
Dima L; Vasile D; Rogozea L; Zia-Ul-Haq M; Bukhari SA; Moga M
Turk J Med Sci; 2015; 45(4):782-8. PubMed ID: 26422846
[TBL] [Abstract][Full Text] [Related]
27. [Atipical antipsychotics in relation with social functioning].
Vrdoljak M; Sesar MA; Ivezić SS
Med Arh; 2007; 61(4):244-7. PubMed ID: 18298001
[TBL] [Abstract][Full Text] [Related]
28. Effects of controlled-release formulations of atypical antipsychotics on functioning and quality of life of schizophrenic individuals.
Ruiu S; Casu MA; Casu G; Piras S; Marchese G
Expert Opin Pharmacother; 2012 Aug; 13(11):1631-43. PubMed ID: 22594805
[TBL] [Abstract][Full Text] [Related]
29. [Impact of olanzapine on quality of life of patients with schizophrenia: one-year follow-up with the Seville Quality of Life Questionnaire].
Giner J; Bobes J; Cervera S; Leal C; Baca E; Ibáñez E
Actas Esp Psiquiatr; 2004; 32(1):1-7. PubMed ID: 14963775
[TBL] [Abstract][Full Text] [Related]
30. Identifying improvable employment-related factors in schizophrenia patients.
Hasegawa T; Hashimoto T; Kanahara N; Yamanaka H; Ishige M; Sato Y; Iyo M
Psychiatry Res; 2018 Aug; 266():199-205. PubMed ID: 29870957
[TBL] [Abstract][Full Text] [Related]
31. Assessment of Psychosocial Functioning in a Large Cohort of Patients with Schizophrenia.
Kossmann C; Heller J; Brüne M; Schulz C; Heinze M; Cordes J; Mühlbauer B; Rüther E; Timm J; Gründer G; Juckel G
Psychiatr Q; 2021 Mar; 92(1):177-191. PubMed ID: 32519208
[TBL] [Abstract][Full Text] [Related]
32. Studies of the course and outcome of schizophrenia in later life.
Cohen CI
Psychiatr Serv; 1995 Sep; 46(9):877-9, 889. PubMed ID: 7583495
[No Abstract] [Full Text] [Related]
33. [The effects of psychosocial skills training on symptomatology, insight, quality of life, and suicide probability in schizophrenia].
Deveci A; Esen-Danaci A; Yurtsever F; Deniz F; Gürlek Yüksel E
Turk Psikiyatri Derg; 2008; 19(3):266-73. PubMed ID: 18791879
[TBL] [Abstract][Full Text] [Related]
34. Quality of life of schizophrenic patients on medications and implications for new drug trials.
Awad AG
Hosp Community Psychiatry; 1992 Mar; 43(3):262-5. PubMed ID: 1348238
[TBL] [Abstract][Full Text] [Related]
35. [Transversal study of the psychosocial rehabilitation and the quality of life of 75 schizophrenics under classical neuroleptics or atypical antipsychotic neuroleptics].
Guillard-Bouhet N; Lafay N; Jourdain M; Senon JL
Encephale; 2005; 31(6 Pt 1):653-65. PubMed ID: 16462684
[TBL] [Abstract][Full Text] [Related]
36. Empirically driven definitions of "good," "moderate," and "poor" levels of functioning in the treatment of schizophrenia.
Ascher-Svanum H; Novick D; Haro JM; Aguado J; Cui Z
Qual Life Res; 2013 Oct; 22(8):2085-94. PubMed ID: 23239123
[TBL] [Abstract][Full Text] [Related]
37. Effects of Psychosocial Day Care Programme on Quality of Life in Patients Affected with Schizophrenia - a Prospective Study.
Juretić TG; Ružić K; Letica-Crepulja M; Petrić D; Dadić-Hero E; Frančišković T
Psychiatr Danub; 2016 Jun; 28(2):111-7. PubMed ID: 27287784
[TBL] [Abstract][Full Text] [Related]
38. Outcome study of first-episode schizophrenia in a developing country: quality of life and antipsychotics.
Chee KY
Soc Psychiatry Psychiatr Epidemiol; 2009 Feb; 44(2):143-50. PubMed ID: 18642120
[TBL] [Abstract][Full Text] [Related]
39. Social functioning as an outcome measure in schizophrenia studies.
Burns T; Patrick D
Acta Psychiatr Scand; 2007 Dec; 116(6):403-18. PubMed ID: 17941964
[TBL] [Abstract][Full Text] [Related]
40. The impact of a rehabilitation day centre program for persons suffering from schizophrenia on quality of life, social functioning and self-esteem.
Štrkalj-Ivezić S; Vrdoljak M; Mužinić L; Agius M
Psychiatr Danub; 2013 Sep; 25 Suppl 2():S194-9. PubMed ID: 23995175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
